All In Biotech

Drug Trial Radar · NCT03960866

Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma

Randomized, Placebo-Controlled, Double-Masked Study of the Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension

Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

39

Actual

Start

May 28, 2019

Primary completion

Sep 11, 2019

Study completion Sep 11, 2019

Sponsor

Lead sponsor
Opus Genetics, IncIndustry
Sponsor type
Industry
First posted
May 23, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objectives of this study are: * To evaluate the efficacy of Phentolamine Mesylate to lower intra-ocular pressure (IOP) in the treatment of Open-Angle Glaucoma (OAG) and Ocular Hypertension (OHT). * To evaluate the ocular and systemic safety of Phentolamine Mesylate compared to its vehicle. * To evaluate additional efficacy of Phentolamine Mesylate to improve visual performance.

Conditions

  • Open Angle Glaucoma
  • Ocular Hypertension

Interventions

  • Phentolamine Mesylate Ophthalmic Solution 1%Drug

    Topical Sterile Ophthalmic Solution

  • Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo)Other

    Topical Sterile Ophthalmic Solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Intraocular PressureTime frame: 15 days

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • North Valley Eye Medical Group

    Mission Hills, California

  • Clayton Eye Clinical Research

    Morrow, Georgia

  • University of Michigan Kellogg Eye Center

    Ann Arbor, Michigan

  • Rochester Ophthalmological Group

    Rochester, New York

  • Abrams Eye Center

    Cleveland, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.